A prospective observational study on evaluating the efficacy of bedside optic nerve sheath diameter in assessing clinical progression of patients admitted in neurosurgical ICU with comparisons to CT scans and GCS score

Background: Ultrasound of the optic nerve sheath diameter (ONSD) is a non-invasive, repeatable tool that can be used to measure intracranial pressure in a dynamic way with high diagnostic accuracy. The goal of this study was to find out if a bedside ultrasonographic measurement of optic nerve sheath diameter (ONSD) can accurately predict the computed tomography (CT) findings of high intracranial pressure (ICP) and changes to the Glasgow Coma Scale (GCS) in adult head injury patients in the Neurosurgery ICU. Methods: For 54 patients in the neurosurgical intensive care unit, we conducted a retrospective analysis of the results of cranial ultrasounds. Those under the age of 18 and those with apparent visual injuries were ineligible. Both horizontal and vertical optic nerve sheath diameters were measured 3 mm beneath the globe in each eye using a 7.5-10MHz ultrasonographic probe. A binocular change in optic nerve sheath diameter of more than 2.00 mm was deemed abnormal in two consecutive readings in the same patient. Patients in the neurosurgical ICU were given a GCS score, which was used to classify their level of brain damage as mild, moderate, or severe. The accuracy of the optic nerve sheath diameter was evaluated using cranial CT findings of shift, oedema, or effacement that suggested an increased intracranial pressure. Results: The research has 54 participants. According to the results, 68.5% of those who took the study were men, while 31.5% of those who did so were women. Nearly 16.7 per cent of respondents were between the ages of 18 and 40, while 40.7% of respondents were between the ages of 40 and 60, and 42.6% of respondents were above 60. The significant change in ONSD- fall in GCS and CT-progression scan-findings correlation was very strong. When compared to CT scan progression, the ONSD bedside sonographic test had an 86.7% sensitivity and an 89.7% specificity for detecting elevated ICP. The Positive Predictive Value of the reduction in GCS with advancement in CT scan was 80% and the Negative Predictive Value was 89.7%, respectively. Conclusions: The sensitivity, specificity, and positive predictive value of bedside ONSD ultrasonography in predicting high intracranial pressure are significant to those of progression in CT scan and drop in GCS. An ONSD bedside measurement may be used to determine elevated ICP since it is non-invasive and repeatable

A prospective observational study on evaluating the efficacy of bedside optic nerve sheath diameter in assessing clinical progression of patients admitted in neurosurgical ICU with comparisons to CT scans and GCS score

Background: Ultrasound of the optic nerve sheath diameter (ONSD) is a non-invasive, repeatable tool that can be used to measure intracranial pressure in a dynamic way with high diagnostic accuracy. The goal of this study was to find out if a bedside ultrasonographic measurement of optic nerve sheath diameter (ONSD) can accurately predict the computed tomography (CT) findings of high intracranial pressure (ICP) and changes to the Glasgow Coma Scale (GCS) in adult head injury patients in the Neurosurgery ICU. Methods: For 54 patients in the neurosurgical intensive care unit, we conducted a retrospective analysis of the results of cranial ultrasounds. Those under the age of 18 and those with apparent visual injuries were ineligible. Both horizontal and vertical optic nerve sheath diameters were measured 3 mm beneath the globe in each eye using a 7.5-10MHz ultrasonographic probe. A binocular change in optic nerve sheath diameter of more than 2.00 mm was deemed abnormal in two consecutive readings in the same patient. Patients in the neurosurgical ICU were given a GCS score, which was used to classify their level of brain damage as mild, moderate, or severe. The accuracy of the optic nerve sheath diameter was evaluated using cranial CT findings of shift, oedema, or effacement that suggested an increased intracranial pressure. Results: The research has 54 participants. According to the results, 68.5% of those who took the study were men, while 31.5% of those who did so were women. Nearly 16.7 per cent of respondents were between the ages of 18 and 40, while 40.7% of respondents were between the ages of 40 and 60, and 42.6% of respondents were above 60. The significant change in ONSD- fall in GCS and CT-progression scan-findings correlation was very strong. When compared to CT scan progression, the ONSD bedside sonographic test had an 86.7% sensitivity and an 89.7% specificity for detecting elevated ICP. The Positive Predictive Value of the reduction in GCS with advancement in CT scan was 80% and the Negative Predictive Value was 89.7%, respectively. Conclusions: The sensitivity, specificity, and positive predictive value of bedside ONSD ultrasonography in predicting high intracranial pressure are significant to those of progression in CT scan and drop in GCS. An ONSD bedside measurement may be used to determine elevated ICP since it is non-invasive and repeatable

A novel parthenin analog exhibits anti-cancer activity: Activation of apoptotic signaling events through robust NO formation in human leukemia HL-60 cells

This study describes the anti-cancer activity of P19, an analog of parthenin. P19 induced apoptosis in HL-60 cells and inhibited cell proliferation with 48 h IC50 of 3.5 lM. At 10 mg/kg dose, it doubled the median survival time of L1210 leukemic mice and at 25 mg/kg it inhibited Ehrlich ascites tumor growth by 60%.Investigation of the mechanism of P19 induced apoptosis in HL-60 cells revealed that N-acetyl-L-cysteine(NAC) and s-methylisothiourea (sMIT) could reverse several molecular events that lead to cell death by inhibiting nitric oxide (NO) formation. It selectively produced massive NO in cells while quenching the basal ROS levels with concurrent elevation of GSH. P19 disrupted mitochondrial integrity leading to cytochrome c release and caspase-9 activation. P19 also caused caspase-8 activation by selectively elevating the expression of DR4 and DR5. All these events lead to the activation of caspase-3 leading to PARP-1 cleavage and DNA fragmentation. However, knocking down of AIF by siRNA also suppressed the apoptosis substantially thus indicating caspase independent apoptosis, too. Further, contrary to enhanced iNOS expression, its transcription factor, NF-jB (p65) was cleaved with a simultaneous increase in cytosolic IjB-alpha. In addition, P19 potently inhibited pro-survival proteins pSTAT3 and survivin. The multimodal pro-apoptotic activity of P19 raises its potential usefulness as a promising anti-cancer therapeutic

A Novel cyano derivative of 11-Keto-β-Boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp-90 cascade, mitochondrial integrity, and other cell survival signaling events in HL-60 cells

Intervention of apoptosis is a promising strategy for discovery of novel anti-cancer therapeutics. In this study, we examined the ability of a novel cyano derivative of 11-keto-b-boswellic acid, that is, butyl 2-cyano-3,11-dioxours-1,12-dien-24-oate (BCDD) to induce apoptosis in cancer cells. BCDD inhibited cell proliferation with 48 h IC50 of 0.67 mM in HL-60, 1 mM in Molt4, and 1.5 mM in THP1 cells. The mechanism of cell death was investigated in HL-60 cells where it caused apoptosis by acting against several potential apoptosis suppressive targets. It inhibited phosphatidylinositol-3-kinase (PI3K)/AKT activity, NF-kB, Hsp-90, and survivin which may enhance the sensitivity of cells to apoptosis.Also, BCDD decreased the activity of Bid and Bax in cytosol, caused DCmt loss, releasing pro-apoptotic cytochrome c, SMAC/DIABLO leading to caspase-9-mediated down stream activation of caspase-3, ICAD, and PARP1 cleavage.Translocation of apoptotis-inducing factor (AIF) from mitochondria to the nucleus indicated some caspases-independent apoptosis. Though it upregulated DR-5 and caspase-8, the caspase inhibitor yet had no effect on apoptosis as against 75% inhibition by caspase-9 inhibitor. Attempts were made to examine any acclaimed role of AIF in the activation of caspase-8 using siRNA where it had no effect on caspase-8 activity while the Bax-siRNA inhibited caspase-3 activation suggesting predominance of intrinsic signaling. Our studies thus demonstrated that BCDD exerts multi-focal action in cancer cells while it required 10-fold higher the concentration to produce cytotoxicity in normal human PBMC and gingival cell line, and therefore, may find usefulness in the management of human leukemia

Abstracts of National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020

This book presents the abstracts of the papers presented to the Online National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020 (RDMPMC-2020) held on 26th and 27th August 2020 organized by the Department of Metallurgical and Materials Science in Association with the Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, India. Conference Title: National Conference on Research and Developments in Material Processing, Modelling and Characterization 2020Conference Acronym: RDMPMC-2020Conference Date: 26–27 August 2020Conference Location: Online (Virtual Mode)Conference Organizer: Department of Metallurgical and Materials Engineering, National Institute of Technology JamshedpurCo-organizer: Department of Production and Industrial Engineering, National Institute of Technology Jamshedpur, Jharkhand, IndiaConference Sponsor: TEQIP-